JF
KRYS icon

Jump Financial’s Krystal Biotech KRYS Stock Holding History

Jump Financial’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,983
Closed -$538K – 1981
2025
Q1 		$538K Buy
+2,983
New +$502K 0.01% 1047
2024
Q2 		– Sell
-9,875
Closed -$1.76M – 2044
2024
Q1 		$1.76M Buy
+9,875
New +$1.37M 0.05% 512

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jump Financial's KRYS Position: Q2 2025 in Review

Jump Financial sold out of Krystal Biotech (KRYS) in Q2 2025, closing a stake of 2,983 shares — an estimated $538K sold.

Jump Financial first reported a position in KRYS in Q1 2024 and held it in 2 quarters. The position peaked at $1.76M in Q1 2024. 275 funds tracked by Wall St. Rank hold KRYS as of Q2 2025.

  • Jump Financial reported no remaining Krystal Biotech position as of Q2 2025 after selling out during the quarter.
  • Jump Financial sold 2,983 Krystal Biotech shares in Q2 2025, an estimated $538K.
  • Jump Financial first reported a position in Krystal Biotech in Q1 2024 and held it in 2 quarters.
  • Jump Financial's Krystal Biotech position peaked at $1.76M in Q1 2024.
  • 275 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2025.

Based on Jump Financial's 13F filing for Q2 2025, filed 13 Aug 2025.